SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K/A
CURRENT
REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 14, 2003
GENTA
INCORPORATED
(Exact
Name of Registrant as Specified in Its Charter)
| Delaware | 0-19635 | 33-0326866 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| Two Connell Drive | ||
| Berkeley Heights, NJ | 07922 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
| (908) 286-9800 | ||
| (Registrant’s Telephone Number, Including Area Code) | ||
| (Former Name or Former Address, if Changed Since Last Report) | ||
The Registrant hereby amends Item 7 of its Form 8-K Report dated August 14, 2003 as follows:
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Statements of Business Acquired
Exhibit 99.2. Audited financial statements of Salus Therapeutics, Inc. for the year ended December 31, 2002.
Exhibit 99.3. Unaudited financial statements of Salus Therapeutics, Inc. for the six months ended June 30, 2003 and 2002.
(b) Pro Forma Financial Information
Exhibit 99.4. Unaudited pro forma consolidated financial statements of Genta Incorporated for the year ended December 31, 2002 and the six months ended June 30, 2003.
(c) Exhibits
Exhibit 23. Consent of Deloitte & Touche LLP
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GENTA INCORPORATED | ||||
| By: | ||||
| /s/ RAYMOND P. WARRELL, JR., M.D. |
||||
| Name: | Raymond P. Warrell, Jr., M.D. | |||
| Title: | Chairman, President, Chief Executive | |||
| Officer and Principal Executive Officer | ||||
| Date: | November 4, 2003 | By: | ||
| /s/ WILLIAM P. KEANE |
||||
| Name: | William P. Keane | |||
| Title: | Vice President, Chief Financial Officer | |||
| and Principal Accounting Officer | ||||
EXHIBIT LIST
| Exhibit | |
| 23. | Consent of Deloitte & Touche LLP |
| 99.2. | Audited financial statements of Salus Therapeutics, Inc. for the year ended December 31, 2002. |
| 99.3. | Unaudited financial statements of Salus Therapeutics, Inc. for the six months ended June 30, 2003 and 2002. |
| 99.4. | Unaudited pro forma consolidated financial statements of Genta Incorporated for the year ended December 31, 2002 and the six months ended June 30, 2003. |